CPIX
Price
$3.31
Change
-$0.35 (-9.56%)
Updated
Sep 5 closing price
Capitalization
49.52M
65 days until earnings call
PAHC
Price
$39.45
Change
+$0.38 (+0.97%)
Updated
Sep 5 closing price
Capitalization
1.6B
59 days until earnings call
Interact to see
Advertisement

CPIX vs PAHC

Header iconCPIX vs PAHC Comparison
Open Charts CPIX vs PAHCBanner chart's image
Cumberland Pharmaceuticals
Price$3.31
Change-$0.35 (-9.56%)
Volume$52.93K
Capitalization49.52M
Phibro Animal Health
Price$39.45
Change+$0.38 (+0.97%)
Volume$480.72K
Capitalization1.6B
CPIX vs PAHC Comparison Chart in %
Loading...
CPIX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PAHC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CPIX vs. PAHC commentary
Sep 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CPIX is a Hold and PAHC is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 07, 2025
Stock price -- (CPIX: $3.31 vs. PAHC: $39.45)
Brand notoriety: CPIX and PAHC are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: CPIX: 74% vs. PAHC: 140%
Market capitalization -- CPIX: $49.52M vs. PAHC: $1.6B
CPIX [@Pharmaceuticals: Generic] is valued at $49.52M. PAHC’s [@Pharmaceuticals: Generic] market capitalization is $1.6B. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $67.95B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.92B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CPIX’s FA Score shows that 0 FA rating(s) are green whilePAHC’s FA Score has 1 green FA rating(s).

  • CPIX’s FA Score: 0 green, 5 red.
  • PAHC’s FA Score: 1 green, 4 red.
According to our system of comparison, PAHC is a better buy in the long-term than CPIX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CPIX’s TA Score shows that 4 TA indicator(s) are bullish while PAHC’s TA Score has 5 bullish TA indicator(s).

  • CPIX’s TA Score: 4 bullish, 5 bearish.
  • PAHC’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, PAHC is a better buy in the short-term than CPIX.

Price Growth

CPIX (@Pharmaceuticals: Generic) experienced а -5.16% price change this week, while PAHC (@Pharmaceuticals: Generic) price change was +6.77% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +0.08%. For the same industry, the average monthly price growth was +12.00%, and the average quarterly price growth was +86.48%.

Reported Earning Dates

CPIX is expected to report earnings on Nov 11, 2025.

PAHC is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Pharmaceuticals: Generic (+0.08% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PAHC($1.6B) has a higher market cap than CPIX($49.5M). PAHC YTD gains are higher at: 90.357 vs. CPIX (39.662). CPIX has less debt than PAHC: CPIX (10.3M) vs PAHC (762M).
CPIXPAHCCPIX / PAHC
Capitalization49.5M1.6B3%
EBITDA3.49MN/A-
Gain YTD39.66290.35744%
P/E RatioN/A33.15-
Revenue42.1MN/A-
Total Cash16.1MN/A-
Total Debt10.3M762M1%
FUNDAMENTALS RATINGS
CPIX vs PAHC: Fundamental Ratings
CPIX
PAHC
OUTLOOK RATING
1..100
1340
VALUATION
overvalued / fair valued / undervalued
1..100
100
Overvalued
29
Undervalued
PROFIT vs RISK RATING
1..100
10037
SMR RATING
1..100
9564
PRICE GROWTH RATING
1..100
5736
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/a49

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

PAHC's Valuation (29) in the Pharmaceuticals Major industry is significantly better than the same rating for CPIX (100) in the Pharmaceuticals Other industry. This means that PAHC’s stock grew significantly faster than CPIX’s over the last 12 months.

PAHC's Profit vs Risk Rating (37) in the Pharmaceuticals Major industry is somewhat better than the same rating for CPIX (100) in the Pharmaceuticals Other industry. This means that PAHC’s stock grew somewhat faster than CPIX’s over the last 12 months.

PAHC's SMR Rating (64) in the Pharmaceuticals Major industry is in the same range as CPIX (95) in the Pharmaceuticals Other industry. This means that PAHC’s stock grew similarly to CPIX’s over the last 12 months.

PAHC's Price Growth Rating (36) in the Pharmaceuticals Major industry is in the same range as CPIX (57) in the Pharmaceuticals Other industry. This means that PAHC’s stock grew similarly to CPIX’s over the last 12 months.

PAHC's P/E Growth Rating (100) in the Pharmaceuticals Major industry is in the same range as CPIX (100) in the Pharmaceuticals Other industry. This means that PAHC’s stock grew similarly to CPIX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CPIXPAHC
RSI
ODDS (%)
N/A
Bearish Trend 3 days ago
71%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
84%
Bearish Trend 3 days ago
61%
Momentum
ODDS (%)
Bullish Trend 3 days ago
82%
Bullish Trend 3 days ago
79%
MACD
ODDS (%)
Bullish Trend 3 days ago
90%
Bullish Trend 3 days ago
72%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
81%
Bullish Trend 3 days ago
70%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
84%
Bullish Trend 3 days ago
73%
Advances
ODDS (%)
Bullish Trend 6 days ago
80%
Bullish Trend 3 days ago
72%
Declines
ODDS (%)
Bearish Trend 28 days ago
79%
Bearish Trend 6 days ago
71%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 3 days ago
69%
Aroon
ODDS (%)
N/A
Bullish Trend 3 days ago
74%
View a ticker or compare two or three
Interact to see
Advertisement
CPIX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PAHC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
DNREX13.480.13
+0.97%
Dunham Real Estate Stock N
INYDX22.67N/A
N/A
Victory Pioneer Disciplined Growth Y
AMCZX18.53N/A
N/A
Alger Mid Cap Growth Z
PORTX61.39-0.03
-0.05%
Trillium ESG Global Equity Investor
JMVPX36.03-0.03
-0.08%
JPMorgan Mid Cap Value R3

CPIX and

Correlation & Price change

A.I.dvisor tells us that CPIX and QNTM have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CPIX and QNTM's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CPIX
1D Price
Change %
CPIX100%
-9.56%
QNTM - CPIX
26%
Poorly correlated
-1.64%
ACB - CPIX
22%
Poorly correlated
+1.66%
ELAN - CPIX
21%
Poorly correlated
+5.50%
PAHC - CPIX
21%
Poorly correlated
+0.97%
BGM - CPIX
20%
Poorly correlated
-2.16%
More

PAHC and

Correlation & Price change

A.I.dvisor indicates that over the last year, PAHC has been loosely correlated with AMRX. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if PAHC jumps, then AMRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PAHC
1D Price
Change %
PAHC100%
+0.97%
AMRX - PAHC
46%
Loosely correlated
+0.73%
ZTS - PAHC
41%
Loosely correlated
+0.08%
PBH - PAHC
38%
Loosely correlated
-2.55%
ELAN - PAHC
37%
Loosely correlated
+5.50%
VTRS - PAHC
36%
Loosely correlated
+1.65%
More